(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
-0.93% $ 365.02
Live Chart Being Loaded With Signals
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific...
Stats | |
---|---|
Объем за сегодня | 360 206 |
Средний объем | 542 498 |
Рыночная капитализация | 26.59B |
EPS | $1.830 ( 2024-04-25 ) |
Дата следующего отчета о доходах | ( $1.820 ) 2024-07-25 |
Last Dividend | $0.200 ( 2023-11-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | 48.09 |
ATR14 | $0.192 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-23 | Pucci Paolo | Buy | 564 | Common Stock |
2024-04-23 | Michels Douglas A | Buy | 564 | Common Stock |
2024-04-23 | Lai Goldman Myla | Buy | 564 | Common Stock |
2024-04-23 | Lockhart Stephen H | Buy | 564 | Common Stock |
2024-04-23 | Keller Deborah L | Buy | 564 | Common Stock |
INSIDER POWER |
---|
-9.46 |
Last 100 transactions |
Buy: 235 088 | Sell: 288 836 |
Объем Корреляция
West Pharmaceutical Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
West Pharmaceutical Корреляция - Валюта/Сырье
West Pharmaceutical Финансовые показатели
Annual | 2023 |
Выручка: | $2.95B |
Валовая прибыль: | $1.13B (38.28 %) |
EPS: | $7.99 |
FY | 2023 |
Выручка: | $2.95B |
Валовая прибыль: | $1.13B (38.28 %) |
EPS: | $7.99 |
FY | 2022 |
Выручка: | $2.89B |
Валовая прибыль: | $1.14B (39.36 %) |
EPS: | $7.88 |
FY | 2021 |
Выручка: | $2.83B |
Валовая прибыль: | $1.18B (41.52 %) |
EPS: | $8.96 |
Financial Reports:
No articles found.
West Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.180 (N/A) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.200 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0163 | 1987-01-26 |
Last Dividend | $0.200 | 2023-11-07 |
Next Dividend | $0 | N/A |
Payout Date | 2023-11-15 | |
Next Payout Date | N/A | |
# dividends | 148 | -- |
Total Paid Out | $11.05 | -- |
Avg. Dividend % Per Year | 0.18% | -- |
Score | 5.52 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.83 | |
Div. Directional Score | 9.81 | -- |
Year | Amount | Yield |
---|---|---|
1987 | $0.0676 | 1.90% |
1988 | $0.0726 | 1.70% |
1989 | $0.0776 | 1.97% |
1990 | $0.100 | 2.12% |
1991 | $0.100 | 3.30% |
1992 | $0.100 | 2.19% |
1993 | $0.103 | 1.82% |
1994 | $0.113 | 1.84% |
1995 | $0.123 | 1.79% |
1996 | $0.133 | 2.23% |
1997 | $0.143 | 2.04% |
1998 | $0.153 | 2.06% |
1999 | $0.163 | 1.86% |
2000 | $0.173 | 2.28% |
2001 | $0.183 | 2.98% |
2002 | $0.190 | 2.85% |
2003 | $0.203 | 3.29% |
2004 | $0.213 | 2.49% |
2005 | $0.225 | 1.78% |
2006 | $0.245 | 1.89% |
2007 | $0.265 | 1.04% |
2008 | $0.285 | 1.41% |
2009 | $0.305 | 1.60% |
2010 | $0.325 | 1.65% |
2011 | $0.345 | 1.65% |
2012 | $0.365 | 1.91% |
2013 | $0.385 | 1.39% |
2014 | $0.410 | 0.84% |
2015 | $0.450 | 0.86% |
2016 | $0.490 | 0.85% |
2017 | $0.530 | 0.63% |
2018 | $0.570 | 0.57% |
2019 | $0.610 | 0.63% |
2020 | $0.650 | 0.43% |
2021 | $0.690 | 0.24% |
2022 | $0.730 | 0.16% |
2023 | $0.770 | 0.33% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
ZTR | Dividend Royal | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.194 | 1.500 | 6.12 | 9.17 | [0 - 0.5] |
returnOnAssetsTTM | 0.158 | 1.200 | 4.74 | 5.69 | [0 - 0.3] |
returnOnEquityTTM | 0.204 | 1.500 | 8.85 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.101 | -1.000 | 8.99 | -8.99 | [0 - 1] |
currentRatioTTM | 2.61 | 0.800 | 1.946 | 1.556 | [1 - 3] |
quickRatioTTM | 1.736 | 0.800 | 4.49 | 3.59 | [0.8 - 2.5] |
cashRatioTTM | 0.928 | 1.500 | 5.95 | 8.93 | [0.2 - 2] |
debtRatioTTM | 0.0851 | -1.500 | 8.58 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 76.61 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.29 | 2.00 | 6.57 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.25 | 2.00 | 7.37 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.114 | -1.500 | 9.54 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.372 | 1.000 | 7.14 | 7.14 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.220 | 1.000 | 7.61 | 7.61 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.47 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.813 | 0.800 | 7.91 | 6.33 | [0.5 - 2] |
Total Score | 12.80 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 47.18 | 1.000 | 5.34 | 0 | [1 - 100] |
returnOnEquityTTM | 0.204 | 2.50 | 9.26 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.25 | 2.00 | 8.25 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.216 | 1.500 | 4.59 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.29 | 2.00 | 6.57 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.101 | 1.500 | 8.99 | -8.99 | [0 - 1] |
pegRatioTTM | 7.55 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.258 | 1.000 | 6.04 | 0 | [0.1 - 0.5] |
Total Score | 6.83 |
West Pharmaceutical
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа